News tagged with cancer cells
Enzyme corrects more than one million faults in DNA replication
Scientists from the Medical Research Council (MRC) Institute of Genetics and Molecular Medicine (IGMM) at the University of Edinburgh have discovered an enzyme that corrects the most common mistake in mammalian DNA.
May 10, 2012 |
4.9 / 5 (16) |
1
|
Scientists unlock key to cancer cell death mystery
An international team of scientists has announced a new advance in the ability to target and destroy certain cancer cells.
Mar 26, 2012 |
5 / 5 (10) |
0
|
Nanoparticle-delivered RNA interference drug stops head and neck cancer growth
(Phys.org) -- A nanoparticle drug delivery vehicle for small interfering RNA molecules (siRNA), that is already being tested in human clinical trials, now shows promise for the treatment of head and neck cancer. Dong Shin, ...
Nanotechnology / Bio & Medicine
Apr 06, 2012 |
5 / 5 (8) |
1
|
Magnetic nanochain detonates chemo barrage inside tumors
Medicine-toting nanochains slip into tumors and explode a chemotherapy drug into hard-to-reach cores of cancer, engineers and scientists at Case Western Reserve University report.
Nanotechnology / Bio & Medicine
Apr 18, 2012 |
5 / 5 (8) |
0
|
'Nanobubbles' plus chemotherapy equals single-cell cancer targeting
Using light-harvesting nanoparticles to convert laser energy into "plasmonic nanobubbles," researchers at Rice University, the University of Texas MD Anderson Cancer Center and Baylor College of Medicine (BCM) ...
Nanotechnology / Bio & Medicine
Apr 09, 2012 |
4.9 / 5 (8) |
0
|
Sunscreen ingredient may pose skin cancer risk, researchers find
(Phys.org) -- As vacationers prepare to spend time outdoors this summer, many of them will pack plenty of sunscreen in hopes it will protect their bodies from overexposure, and possibly from skin cancer. But researchers at ...
Nanotechnology / Nanomaterials
May 08, 2012 |
4.5 / 5 (8) |
10
|
Gamma ray optics: A viable tool for a new branch of scientific discovery
Scientists at the Institut Laue-Langevin (ILL) have demonstrated for the first time that gamma rays, a highly energetic form of light produced by radioactive decay of atomic nuclei and amongst other used to ...
May 09, 2012 |
4.3 / 5 (8) |
2
Researchers use nanoparticles, magnetic current to damage cancerous cells in mice
Using nanoparticles and alternating magnetic fields, University of Georgia scientists have found that head and neck cancerous tumor cells in mice can be killed in half an hour without harming healthy cells.
Nanotechnology / Bio & Medicine
Mar 27, 2012 |
5 / 5 (6) |
1
|
'Bed-of-nails' breast implant deters cancer cells
One in eight women in the United States will develop breast cancer. Of those, many will undergo surgery to remove the tumor and will require some kind of breast reconstruction afterward, often involving implants. ...
Nanotechnology / Bio & Medicine
Mar 23, 2012 |
3.9 / 5 (7) |
0
|
Tiny hitchhikers attack cancer cells: Gold nanostars first to deliver drug directly to cancer cell nucleus
Nanotechnology offers powerful new possibilities for targeted cancer therapies, but the design challenges are many. Northwestern University scientists now are the first to develop a simple but specialized nanoparticle that ...
Nanotechnology / Bio & Medicine
Apr 05, 2012 |
5 / 5 (4) |
0
|
Study shows potential to revive abandoned cancer drug by nanoparticle drug delivery
Current nanomedicine research has focused on the delivery of established and novel therapeutics. But a UNC team is taking a different approach. They developed nanoparticle carriers to successfully deliver therapeutic doses ...
Nanotechnology / Bio & Medicine
May 02, 2012 |
5 / 5 (4) |
0
|
Soybeans soaked in warm water naturally release key cancer-fighting substance
Soybeans soaking in warm water could become a new "green" source for production of a cancer-fighting substance now manufactured in a complicated and time-consuming industrial process, scientists are reporting ...
May 09, 2012 |
5 / 5 (4) |
1
Protein 'jailbreak' helps breast cancer cells live
If the fight against breast cancer were a criminal investigation, then the proteins survivin, HDAC6, CBP, and CRM1 would be among the shadier figures. In that vein, a study to be published in the March 30 ...
Mar 28, 2012 |
4.8 / 5 (4) |
0
|
Using radio waves to bake tumors
(Phys.org) -- Nanothermal therapy the use of nanoparticles to cook a tumor to death is one of the many promising uses of nanotechnology to both improve the effectiveness of cancer therapy and reduce its side ...
Nanotechnology / Bio & Medicine
Apr 06, 2012 |
4.8 / 5 (4) |
2
|
Scientists identify major source of cells' defense against oxidative stress
Both radiation and many forms of chemotherapy try to kill tumors by causing oxidative stress in cancer cells. New research from USC on a protein that protects cancer and other cells from these stresses could one day help ...
Apr 06, 2012 |
4.5 / 5 (4) |
0
|
Cancer
Cancer (medical term: malignant neoplasm) is a class of diseases in which a group of cells display uncontrolled growth (division beyond the normal limits), invasion (intrusion on and destruction of adjacent tissues), and sometimes metastasis (spread to other locations in the body via lymph or blood). These three malignant properties of cancers differentiate them from benign tumors, which are self-limited, and do not invade or metastasize. Most cancers form a tumor but some, like leukemia, do not. The branch of medicine concerned with the study, diagnosis, treatment, and prevention of cancer is oncology.
Cancer may affect people at all ages, even fetuses, but the risk for most varieties increases with age. Cancer causes about 13% of all human deaths. According to the American Cancer Society, 7.6 million people died from cancer in the world during 2007. Cancers can affect all animals.
Nearly all cancers are caused by abnormalities in the genetic material of the transformed cells. These abnormalities may be due to the effects of carcinogens, such as tobacco smoke, radiation, chemicals, or infectious agents. Other cancer-promoting genetic abnormalities may be randomly acquired through errors in DNA replication, or are inherited, and thus present in all cells from birth. The heritability of cancers are usually affected by complex interactions between carcinogens and the host's genome. New aspects of the genetics of cancer pathogenesis, such as DNA methylation, and microRNAs are increasingly recognized as important.
Genetic abnormalities found in cancer typically affect two general classes of genes. Cancer-promoting oncogenes are typically activated in cancer cells, giving those cells new properties, such as hyperactive growth and division, protection against programmed cell death, loss of respect for normal tissue boundaries, and the ability to become established in diverse tissue environments. Tumor suppressor genes are then inactivated in cancer cells, resulting in the loss of normal functions in those cells, such as accurate DNA replication, control over the cell cycle, orientation and adhesion within tissues, and interaction with protective cells of the immune system.
Diagnosis usually requires the histologic examination of a tissue biopsy specimen by a pathologist, although the initial indication of malignancy can be symptoms or radiographic imaging abnormalities. Most cancers can be treated and some cured, depending on the specific type, location, and stage. Once diagnosed, cancer is usually treated with a combination of surgery, chemotherapy and radiotherapy. As research develops, treatments are becoming more specific for different varieties of cancer. There has been significant progress in the development of targeted therapy drugs that act specifically on detectable molecular abnormalities in certain tumors, and which minimize damage to normal cells. The prognosis of cancer patients is most influenced by the type of cancer, as well as the stage, or extent of the disease. In addition, histologic grading and the presence of specific molecular markers can also be useful in establishing prognosis, as well as in determining individual treatments.
For more information about Cancer, read the full article at
Wikipedia.
This text uses material from Wikipedia and is available under the GNU Free Documentation License.